Hypera (BSP:HYPE3) 3-Year EBITDA Growth Rate : 23.20% (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Hypera 3-Year EBITDA Growth Rate?

Hypera's EBITDA per Share for the three months ended in Dec. 2023 was R$0.97.

During the past 12 months, Hypera's average EBITDA Per Share Growth Rate was 4.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 23.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 20.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 13.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Hypera was 126.70% per year. The lowest was -9.90% per year. And the median was 12.95% per year.

Competitive Comparison of Hypera's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Hypera's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypera's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hypera's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Hypera's 3-Year EBITDA Growth Rate falls into.

Hypera 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Hypera (BSP:HYPE3) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Hypera 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Hypera's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Hypera (BSP:HYPE3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (BSP:HYPE3) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

HYPMY:USA HM6A:Germany

Address

Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120

Website

https://www.hypermarcas.com.br

Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and Non-Retail Market.

Hypera (BSP:HYPE3) Headlines

No Headlines